Investigations

Created At
Go
18 Investigations visible to you, out of a total of 18
No description specified

Submitter: René Hänsel

Studies: ACT-2

Resources: ACT-2 trial data, ACT-2 trial metadata

No description specified

Submitter: René Hänsel

Studies: Flyer

Resources: FLYER trial data, FLYER trial metadata

Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.

Submitter: René Hänsel

Studies: MegaCHOEP Phase III

Resources: No Resources

RICOVER-60 is a randomised study comparing 6 and 8 cycles of chemotherapy with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 14-day intervals (CHOP-14), both with or without the monoclonal anti-CD20 antibody Rituximab in patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

No description specified
No description specified
Powered by
(v.1.13.0-master)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig

By continuing to use this site you agree to the use of cookies